Serum vaccine antibody concentrations in children exposed to perfluorinated compounds.

Authors:
Address: Department of Environmental Health, Harvard School of Public Health, 401 Park Dr, EOME 3E-110, Boston, MA 02215, USA. pgrand@hsph.harvard.edu
Journal:


Publication:

abstract

CONTEXT:

perfluorinated compounds (PFCs) have emerged as important food contaminants. They cause immune suppression in a rodent model at Serum concentrations similar to those occurring in the US population, but adverse health effects of PFC exposure are poorly understood.

OBJECTIVE:

To determine whether PFC exposure is associated with antibody response to childhood vaccinations.

DESIGN, SETTING, AND PARTICIPANTS:

Prospective study of a birth cohort from the National Hospital in the Faroe Islands. A total of 656 consecutive singleton births were recruited during 1997-2000, [corrected] and 587 participated in follow-up through 2008.

MAIN OUTCOME MEASURES:

Serum antibody concentrations against tetanus and diphtheria toxoids at ages 5 and 7 years.

RESULTS:

Similar to results of prior studies in the United States, the PFCs with the highest serum concentrations were perfluorooctane sulfonic acid (PFOS) and perfluorooctanoic acid (PFOA). Among PFCs in maternal pregnancy serum, PFOS showed the strongest negative correlations with antibody concentrations at age 5 years, for which a 2-fold greater concentration of exposure was associated with a difference of -39% (95% CI, -55% to -17%) in the diphtheria antibody concentration. PFCs in the child's serum at age 5 years showed uniformly negative associations with antibody levels, especially at age 7 years, except that the tetanus antibody level following PFOS exposure was not statistically significant. In a structural equation model, a 2-fold greater concentration of major PFCs in child serum was associated with a difference of -49% (95% CI, -67% to -23%) in the overall antibody concentration. A 2-fold increase in PFOS and PFOA concentrations at age 5 years was associated with odds ratios between 2.38 (95% CI, 0.89 to 6.35) and 4.20 (95% CI, 1.54 to 11.44) for falling below a clinically protective level of 0.1 IU/mL for tetanus and diphtheria antibodies at age 7 years.

CONCLUSION:

Elevated exposures to PFCs were associated with reduced humoral immune response to routine childhood immunizations in children aged 5 and 7 years.



Related Articles
The effect of prenatal perfluorinated chemicals exposures on pediatric atopy.
Environ Res. 2011
The effect of prenatal perfluorinated chemicals exposures on pediatric atopy.
Wang IJ, Hsieh WS, Chen CY, Fletcher T, Lien GW, Chiang HL, Chiang CF, Wu TN, Chen PC. Environ Res. 2011 Aug; 111(6):785-91. Epub 2011 May 23.
Reduced antibody responses to vaccinations in children exposed to polychlorinated biphenyls.
PLoS Med. 2006
Reduced antibody responses to vaccinations in children exposed to polychlorinated biphenyls.
Heilmann C, Grandjean P, Weihe P, Nielsen F, Budtz-Jørgensen E. PLoS Med. 2006 Aug; 3(8):e311.
Final Report on Carcinogens Background Document for Styrene.
Rep Carcinog Backgr Doc. 2008
Final Report on Carcinogens Background Document for Styrene.
National Toxicology Program. Rep Carcinog Backgr Doc. 2008 Sep; (8-5978):i-398.
Review Perfluorinated substances in human food and other sources of human exposure.
Rev Environ Contam Toxicol. 2010
Review Perfluorinated substances in human food and other sources of human exposure.
D'Hollander W, de Voogt P, De Coen W, Bervoets L. Rev Environ Contam Toxicol. 2010; 208:179-215.
Review Environmental exposure to polychlorinated biphenyls (PCBs) and dioxins. Consequences for longterm neurological and cognitive development of the child lactation.
Adv Exp Med Biol. 2000
Review Environmental exposure to polychlorinated biphenyls (PCBs) and dioxins. Consequences for longterm neurological and cognitive development of the child lactation.
Boersma ER, Lanting CI. Adv Exp Med Biol. 2000; 478:271-87.
Perfluorinated compounds may lower vaccine protection in children.
Environ Health Perspect. 2012
Perfluorinated compounds may lower vaccine protection in children.
Potera C. Environ Health Perspect. 2012 Apr; 120(4):A150-1.

To top Home


Show map | Diseases | Vaccination | Chronic disease | Medicine | Pregnancy | Heat & Sunburn | Cold | Security | Useful tips | Faq | News

TraveldoctorOnline 2001 • Disclaimer webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.